Skip to main content
Signal8
Ruiz Briseno Andres profile photo

Briseno Andres Ruiz

CIK: 0001983118

Transaction Breakdown

Open Market Buys (P)0 (0.0%)

High conviction signal

Open Market Sales (S)1 (16.7%)

Position reduction

Option Exercises (M)1 (16.7%)

Derivative conversions

Awards (A)4 (66.7%)

Compensation grants

Other (G, F, J, C, D, …)0 (0.0%)

Gifts, tax withholding, conversions, dispositions to the issuer and other codes

Companies & Roles (1)

IDEAYA Biosciences, Inc. logo
IDYA

IDEAYA Biosciences, Inc.

Officer

Discretionary Trading P&L

Holdings

Transaction History (6 total)

  • IDEAYA Biosciences, Inc. logo
    IDYA

    IDEAYA Biosciences, Inc.

    Jul 7, 2026
    Exercise(M)
    Direct
    9.6K shares at avg. $12.86$123K
  • IDEAYA Biosciences, Inc. logo
    IDYA

    IDEAYA Biosciences, Inc.

    Jul 7, 2026
    Sale(S)
    Direct
    9.6K shares at avg. $40.01$382K
  • IDEAYA Biosciences, Inc. logo
    IDYA

    IDEAYA Biosciences, Inc.

    Jan 30, 2026
    Award(A)

    Stock Option (right to buy)

    Direct
    80K shares-
  • IDEAYA Biosciences, Inc. logo
    IDYA

    IDEAYA Biosciences, Inc.

    Nov 28, 2025
    Award(A)
    Direct
    1.3K shares at avg. $16.91$21K
  • IDEAYA Biosciences, Inc. logo
    IDYA

    IDEAYA Biosciences, Inc.

    Feb 27, 2025
    Award(A)

    Stock Option (right to buy)

    Direct
    75K shares-
  • IDEAYA Biosciences, Inc. logo
    IDYA

    IDEAYA Biosciences, Inc.

    Nov 29, 2024
    Award(A)
    Direct
    682 shares at avg. $23.26$16K

1-6 of 6

About Ruiz Briseno Andres

Ruiz Briseno Andres (SEC CIK 0001983118) files insider reports with the SEC as Chief Accounting Officer of IDEAYA Biosciences, Inc. (IDYA).

Signal8 holds 3 ownership filings by Ruiz Briseno Andres, all Form 4s, filed between Feb 28, 2025 and Jul 9, 2026. Those filings report 6 transactions, from Nov 29, 2024 to Jul 7, 2026. Signal8's Form 4 history starts in Sep 2024.

The business address on Ruiz Briseno Andres's filings is in SOUTH SAN FRANCISCO, CA.

Recent filings by Ruiz Briseno Andres

  • Jul 7, 2026: Option exercise of IDYA shares (Form 4, code M).
  • Jul 7, 2026: Open-market sale of IDYA shares (Form 4, code S).
  • Jan 30, 2026: Grant or award of IDYA derivative securities (Form 4, code A).
  • Nov 28, 2025: Grant or award of IDYA shares (Form 4, code A).
  • Feb 27, 2025: Grant or award of IDYA derivative securities (Form 4, code A).

Other insiders filing for IDEAYA Biosciences, Inc. (IDYA)

How to read Form 4 transaction codes